Red blood cell distribution width (RDW) is a quantitative
|
|
- Reginald Gordon
- 5 years ago
- Views:
Transcription
1 Effect of Exercise Training on Red Blood Cell Distribution Width as a Marker of Impaired Exercise Tolerance in Patients With Coronary Artery Disease Summary Yasuhiro Nishiyama, 1 MD, Hiroshi Niiyama, 1 MD, Haruhito Harada, 1 MD, Atsushi Katou, 1 MD, Noriko Yoshida, 1 MD, and Hisao Ikeda, 1 MD Red blood cell distribution width (RDW) can predict mortality in cardiovascular disease. However, the underlying mechanisms of the beneficial prognostic marker remain unknown. The purpose of this study was to investigate whether the RDW is related to impaired exercise tolerance and exercise training (ET) effect on RDW in patients with coronary artery disease (CAD). Seventy-eight patients who underwent ET by supervised bicycle ergometer during 3 weeks served as the ET group whereas 30 patients who did not undergo ET were the control group. Exercise stress test with cardiopulmonary analysis was performed in the ET group. Peak oxygen uptake (from 14.1 ± 4.0 to 15.1 ± 3.8 ml/kg/minute, P < 0.05) significantly increased in the ET group. Although RDW and serum erythropoietin concentration (EP) before the observation period did not differ between the ET and control groups, RDW (from 44.4 ± 4.7 to 43.4 ± 3.8 fl, P < 0.01) and EP (from 27.9 ± 15.8 to 22.9 ± 8.2 miu/ml, P < 0.005) significantly decreased in the ET group, however, these parameters did not change in the control group. In the ET group, RDW was negatively correlated with peak oxygen uptake (r = -0.55, P < 0.01) and the changes in RDW before and after ET were positively correlated with the changes in EP (r = 0.39, P < 0.005). Thus, ET increases exercise tolerance and decreases RDW in association with increased oxygen uptake in patients with CAD. (Int Heart J 2016; 57: ) Key words: Erythropoietin, Exercise stress test, Oxygen uptake, Oxygen transport Red blood cell distribution width (RDW) is a quantitative measure of anisocytosis, the variability in size of the circulating erythrocytes. In general, higher RDW reflects increased red blood cell destruction such as hemolytic disorders and nutritional deficiency including iron, vitamin B 12, and folate deficiency. Recent studies showed a strong independent association between higher levels of RDW and the risk of adverse cardiovascular outcomes in patients with heart failure, coronary artery disease, and pulmonary hypertension. 1-5) However, the underlying mechanisms of the beneficial prognostic marker remain unknown. Red blood cells transport oxygen to tissues such as peripheral muscle. Increased RDW signifies increased red blood cells with incomplete oxygen binding with hemoglobin such as premature erythrocytes or iron deficiency anemia. Accordingly, we speculate that higher levels of RDW may affect oxygen transport capacity, which is associated with adverse clinical outcomes. 1-5) Exercise training increases aerobic capacity and exercise tolerance, 6) and improves prognosis in patients with coronary artery disease (CAD). A previous study has shown that higher levels of RDW were related to impaired exercise capacity and exercise training decreased RDW in patients with chronic heart failure, 7) but no study has reported them in patients with CAD. Therefore, we investigated whether RDW is related to impaired exercise tolerance and exercise training effect on RDW in patients with CAD. Methods Study patients: The study population consisted of 108 patients with stable CAD who were admitted to Kurume University Medical Center. CAD was defined as the presence of visible luminal narrowing (> 50%) in at least one of the 15 coronary segments according to the American Heart Association and having the symptoms of chest pain with ischemic electrocardiographic changes. All subjects received coronary angiography to diagnose CAD. Of these, 20 had a previous myocardial infarction, and 88 patients had a history of angina with no evidence of previous infarction. Forty-six patients had prior percutaneous intervention and 10 had coronary artery bypass graft surgery. All patients were Grade 1 of Canadian Car- From the 1 Department of Cardiology, Kurume University Medical Center, Fukuoka, Japan. Address for correspondence: Yasuhiro Nishiyama, MD, Department of Cardiology, Kurume University Medical Center, Kokubu-machi, Kurume, Fukuoka , Japan. ynishi@orange.ocn.ne.jp Received for publication January 8, Revised and accepted March 9, Released in advance online on J-STAGE September 1, All rights reserved by the International Heart Journal Association. 553
2 554 NISHIYAMA, ET AL Int Heart J September 2016 diovascular Society stable angina. 8) All patients underwent complete routine physical and laboratory examinations, and their complete anamnesis was obtained. Of the 108 patients, 78 were eligible for cardiac rehabilitation and the remaining 30 who were unable to perform the exercise stress test and cardiac rehabilitation because of orthopedic or neuromuscular disease were allocated to the control group. Patients with atrioventricular block and pacemaker implantation, severe renal failure, severe hepatic disease, malignant neoplasmas, or who received blood transfusion within 3 months were excluded from the study. All patients received conventional drug therapy. In these patients, medications included angiotensin converting enzyme inhibitors or angiotensin receptor blockers (n = 72), aspirin (n = 65), HMG-CoA inhibitors (n = 57), antithrombotic agents (n = 48), calcium channel antagonists (n = 47), vasodilators (n = 41), β blockers (n = 37), and diuretics (n = 27). Medication therapy was not changed during the study period. Informed consent was obtained from all patients, and the study was approved by the Human Study Committee of our institution. Blood samples and hormone measurements: Blood samples were collected in the morning following an overnight fast before and after exercise training in the training group, or at the same period in the control group in the hospital. After supine rest for at least 20 minutes, a sample was taken from the antecubital vein and after immediate centrifugation, aliquots were stored at 70 C until analysis. Complete blood count was determined using an XT-2000 automated cell counter (Sysmex, Kobe, Japan) with standard calibration. The RDW standard deviation was taken at the 20% relation height level, with the red cell histogram peak considered to be 100%. The red cell histogram crosses the 20% level twice. The distance between the two cross points was defined as RDW and is reported in femtoliters (fl). The erythropoietin levels were measured by radioimmunoassay. Exercise stress test and exercise training: Seventy-eight patients underwent a symptom-limited exercise stress test before and after exercise training. Exercise stress tests were performed with an electrically braked bicycle ergometer (BE250 Fukuda Denshi, Tokyo). A ramp protocol, starting at a workload of 20 watts and increased incrementally by 1 watt every 6 seconds (10W/minute) was used. The ECG and SBP were recorded every minute before, during, and after exercise (ML- 9000, Fukuda Denshi, Tokyo). Criteria for stopping the exercise test included life-threatening arrhythmias, ST-segment depression or elevation > 0.2 mv, a fall in SBP > 20 mmhg, or predicted target heart rate (HR) [(220 age) 0.85]. In 62 patients, expired gas was collected and analyzed continuously with an AE-310S gas analyzer (Minato Co, Osaka, Japan). Peak oxygen uptake (VO 2 ) was defined as the highest VO 2 value achieved at peak exercise. The anaerobic threshold (AT) was defined using the V-slope method. The slope of the relationship between ventilation (VE) and carbon dioxide production (VCO 2 ) (VE/VCO 2 slope) as a marker of ventilator inefficiency, was determined by linear regression. Exercise tolerance (metabolic equivalents, METs) was calculated by the following formula: Workload (watts) / Body Weight (kg) 35, or Peak VO 2 / 3.5. Twenty minutes of supervised bicycle training was performed every day for 3 weeks in the hospital. Exercise intensity was 70% of peak workload or AT level, determined by the entry exercise test. Statistical analysis: Values are presented as the mean ± standard deviation (SD). The comparisons between groups were made by the unpaired t-test and χ 2 test. Serial changes were compared by the paired t-test. Correlations of RDW with various parameters were examined by Pearson correlation analysis. We investigated the association with RDW and peak VO 2 before and after exercise training with analysis of covariance (ANCOVA). All statistical analyses were performed using an SPSS system. Skewed variables were log-transformed. A probability value of < 0.05 was considered significant. Results Baseline characteristics: Baseline characteristics of the enrolled patients are shown in Table I. The training and control groups did not differ in terms of age, sex, body mass index, myocardial infarction, PCI/CABG, EF, complications, and medication. Renal function, such as serum creatinine and estimated glomerular filtration (egfr), was significantly decreased in the control group compared to the training group. Clinical and hematological parameters: Clinical and hematological parameters of the enrolled patients are shown in Table II. Exercise tolerance (METs) significantly increased after exercise training. RDW, hemoglobin, and erythropoietin concentration significantly decreased after exercise training. These parameters did not change in the control group during the observation period. Mean corpuscular volume (MCV) did not change in either group after training or after the observation period. RDW, MCV, and erythropoietin concentration after the observation period in the control group were significantly larger than those after exercise training in the training group. Hemoglobin in the control group was significantly lower than those before and after exercise training in the training group. Cardiopulmonary parameters before and after exercise training: Exercise parameters in the cardiopulmonary exercise test are shown in Table III. Systolic blood pressure at rest and peak exercise significantly decreased after exercise training. Oxygen uptake at anaerobic threshold and peak exercise significantly increased after exercise training. However, heart rate at rest and peak exercise, peak workload, peak VO 2 /HR (oxygen pulse), ΔVO 2 /Δwork load, and VE/VCO 2 slope did not change before and after exercise training. Correlation between RDW and peak oxygen uptake: Figure 1 shows the correlation between RDW and peak VO 2. Significant inverse correlations were observed between peak VO 2 and RDW before (r = -0.36, P < 0.01) and after exercise training (r = -0.55, P < 0.01), respectively. These correlations were significantly stronger after exercise training than before exercise training (P < ). Correlation between the changes in RDW and erythropoietin before and after exercise training: Figure 2 shows the correlation between changes in RDW and changes in erythropoietin concentration after exercise training. A significant correlation was observed between the changes in RDW and changes in erythropoietin concentration (r = 0.39, P < 0.01). Discussion In the present study, we demonstrated that RDW was sig-
3 Vol 57 No 5 EFFECT OF EXERCISE TRAINING ON RDW 555 Table I. Baseline Characteristics of the Enrolled Patients Training (n = 78) Control (n = 30) P Age 69 ± ± 10 NS Sex (Male/Female) 48/30 19/11 NS Body mass index (kg/m 2 ) 23.7 ± ± 3.7 NS MI 16 4 NS PCI/CABG 36/7 10/3 NS EF 61 ± ± 14 NS Creatinine 0.8 ± ± 0.6 P < 0.05 egfr 66.7 ± ± 21.9 P < 0.05 Complication Hypertension 57 (73) 22 (73) NS Hyperlipidemia 39 (50) 15 (50) NS Diabetes mellitus 30 (38) 7 (23) NS Medication ACI/ARB 47 (60) 25 (83) NS Ca 30 (38) 17 (57) NS Statin 40 (51) 9 (30) NS β-blocker 29 (37) 8 (27) NS Vaso 25 (32) 16 (53) NS Diu 18 (23) 9 (30) NS A-P 49 (63) 16 (53) NS A-T 31 (40) 17 (57) NS Values are mean ± SD or number (%) as indicated. PCI indicates percutaneous coronary intervention; CABG, coronary artery bypass grafting; EF, ejection fraction; egfr, estimated glomerular filtration rate; ACI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; Ca, calcium-channel antagonist; Statin, HMG-CoA reductase inhibitor; Vaso, vasodilator; Diu, diuretics; A-P, antiplatelet agent; A-T, antithrombotic agent; and NS, not significant. Table II. Clinical and Hematological Parameters of the Enrolled Patients Training Control Before After Before After RDW (fl) 44.4 ± ± 3.8 ** 46.4 ± ± 6.1 ## Hemoglobin (g/dl) 13.0 ± ± 2.0 * 12.0 ± 1.5 # 11.7 ± 1.7 # MCV (fl) 93.2 ± ± ± ± 4.2 # Erythropoietin (miu/ml) 27.9 ± ± 8.2 * 28.6 ± ± 8.3 # METs 5.0 ± ± 2.0 ** Values are mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001, before versus after. # P < 0.05, ## P < 0.01, Training versus Control. RDW indicates red cell distribution width; MCV, mean corpuscular volume; and METs, metabolic equivalents. Table III. Cardiopulmonary Parameters Before and After Exercise Training Before After P Heart Rate (rest) 72 ± ± 11 NS. Heart Rate (peak exercise) 118 ± ± 19 NS. SBP (rest, mmhg) 123 ± ± 18 P < 0.01 SBP (peak exercise) 175 ± ± 32 P < 0.05 Peak Work Load (watts) 76 ± ± 28 NS AT VO 2 (ml/kg/minute) 9.5 ± ± 2.3 P < 0.05 Peak VO 2 (ml/kg/minute) 14.1 ± ± 3.8 P < 0.05 Peak VO 2 /HR (ml/beat) 7.7 ± ± 2.7 NS ΔVO 2 /Δ Load (ml/watt) 8.15 ± ± 2.95 NS VE/VCO 2 slope 32.4 ± ± 6.2 NS Values are mean ± SD. SBP indicates systolic blood pressure; AT, anaerobic threshold; VO 2, oxygen uptake; HR, heart rate; VE, ventilation; VCO 2, carbon dioxide production; and NS, not significant. nificantly related to peak VO 2 in patients with CAD. Furthermore, exercise training significantly increased exercise tolerance, and decreased RDW and erythropoietin concentrations. Thus, our findings, to the best of our knowledge, provide the first demonstration that exercise training increases exercise tolerance and decreases RDW in association with decreased erythropoietin concentration in patients with CAD. Increased RDW is a strong independent predictor of morbidity and mortality in patients with cardiovascular disease including heart failure, coronary artery disease, and pulmonary
4 556 NISHIYAMA, ET AL Int Heart J September 2016 Figure 1. Relationship of red blood cell distribution width (RDW) and peak VO 2. Note that a significant correlation was observed between RDW and peak VO 2. Figure 2. Relationship of changes in red blood cell distribution width (RDW) and the changes in erythropoietin concentration (EPO) before and after exercise training. Note that a significant correlation was observed between the changes in RDW and the changes in EPO before and after exercise training. hypertension. 1-5) Furthermore, Oh, et al showed a novel relation between higher RDW and elevated E/E (early mitral inflow velocity to early diastolic mitral annual velocity) in patients with acute heart failure, suggesting that RDW is associated with elevated left ventricular filling pressure. 9) Fukuta, et al showed that higher RDW was associated with elevated BNP in patients with CAD, suggesting that neurohumoral activation is a mechanistic link between increased RDW and adverse clinical outcomes in patients with CAD. 10) However, the possible mechanisms of higher RDW levels and adverse cardiovascular outcomes in patients with CAD remained unclear. Higher levels of RDW suggest immature red blood cell production in bone marrow and increased red blood cells with incomplete oxygen binding with hemoglobin. Therefore, increased RDW may affect oxygen transport and exercise tolerance. In our study, RDW negatively related to peak VO 2 in CAD patients, and was especially stronger after exercise training. Peak VO 2 is considered as a standard of exercise tolerance and reflects both cardiac performance and the capacity of peripheral working muscles to extract transported oxygen. 11) There was no significant relationship between the change in RDW and change in peak VO 2 before and after exercise training in our study. The reason is unclear. However, we thought that a decrease in RDW after exercise training would lead to increased oxygen transport and extraction of oxygen in contracting muscle and improved exercise capacity (increased peak VO 2 ). A decrease in RDW might be proportional to the increase in oxygen delivery, but not be proportional to extracted oxygen in contracting muscle. Our findings indicate that RDW reflects oxygen transport capacity and a reduction in oxygen transport capacity may be one of the mechanisms responsible for the relationship between increased RDW and poor prognosis in cardiovascular disease. Exercise training increased peak VO 2 and improved prognosis in CAD patients. Further investigations are needed to provide a more convincing explanation. Exercise training significantly decreased RDW and erythropoietin levels in this study. Although a previous study showed that exercise training decreased RDW in chronic heart failure patients, 7) no study has been conducted in patients with CAD. Additionally, our study showed a significant correlation between changes in RDW and changes in erythropoietin concentration. This suggests that the variability of RDW was induced by erythrocyte proliferation in the bone marrow. Thus, our study is the first report of an exercise training effect on RDW in CAD patients. A previous study demonstrated that exogenous erythropoietin treatment resulted in an increase of hemoglobin concentration leading to increased oxygen delivery and improved exercise capacity ) These results seem at first sight to be opposite to our results. However, we assessed that exercise training decreased RDW leading to increase oxygen binding with hemoglobin and oxygen delivery, and improved exercise capacity. In the body, an increase of oxygen delivery causes negative feedback on endogenous erythropoietin concentration and a decrease in erythropoietin concentration after exercise training. Possible mechanisms underlying the beneficial effects of exercise training on RDW may be considered. In general, exercise training in CAD patients decreases proinflammatory cytokine production and induces inducible nitric oxide synthase expression and antioxidative effects, 16,17) leading to enhanced erythroid proliferation in red bone marrow. Zhao, et al showed that exercise training altered erythrocyte deformability and decreased the abnormality ratio of erythrocyte shape, resulting in enhanced oxygen delivery. 18) Schmidt, et al reported that exercise training increased the 2,3-diphosphoglycerate concentration of red blood cells and oxygen transport capacity. 19) Thus, several mechanisms for the effects of exercise training on RDW may be considered although further study is needed. In this study, hemoglobin concentration decreased after exercise training. A previous study demonstrated that the decrease in hemoglobin concentration was transient and occurred in the early phase of training and then returned to pretraining levels. 19) Additionally, another study reported that hypervolemia induced by exercise training led to a decrease in hemoglobin concentration ) If anemia (decrease in total hemoglobin volume) is true in this study, mean corpuscular volume should have decreased and erythropoietin concentration should have increased, but they did not in fact. Therefore, it is thought that the decrease in hemoglobin concentration after exercise training in our study did not affect RDW. Several limitations in this study are worth mentioning.
5 Vol 57 No 5 EFFECT OF EXERCISE TRAINING ON RDW 557 First, we did not directly measure oxygen delivery. However, since cardiopulmonary analysis exactly reflects oxygen delivery during exercise, this did not influence our conclusion. Second, most of the RDW values varied within the normal range. In the CARE study which showed a graded independent relation between higher levels of RDW and the risk of death and cardiovascular events in patients with CAD, 2) RDW levels were within the normal range in most of the patients. Therefore, our study findings have relevant clinical significance. Third, patients in the control group had a greater degree of renal dysfunction and lower hemoglobin than those in the training group. Although erythropoietin concentration, hemoglobin, and complications (diabetes mellitus and hyperlipidemia) at study entry were determining factors of RDW in stepwise multiple linear regression analysis (data not shown), erythropoietin concentration and rate of complication (diabetes mellitus and hyperlipidemia) did not differ between the groups. Additionally, RDW in the control group might be variable for lower hemoglobin, but did not change before and after the observation periods. Although medication such as statin or antiplatelet agents may have an effect on RDW, these medications were not determining factors in the stepwise multiple linear regression analysis and the rate of medication did not differ in either the control or exercise training group. Based on these results, RDW might decrease after exercise training. Finally, the number of patients was small and they were middle aged. Further investigations are needed to provide a more convincing conclusion in a larger number of patients with a wide range of age. In conclusion, the present study, to the best of our knowledge, provides the first demonstration that RDW is associated with impaired oxygen uptake and erythropoietin concentration in patients with CAD. This finding may be one of the underlying mechanisms of increased RDW and a poor prognosis in cardiovascular disease. Acknowledgment The authors wish to thank Ms. Emiko Shiotani for her excellent secretary assistance. References 1. Felker GM, Allen LA, Pocock SJ, et al; CHARM Investigators. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 2007; 50: Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M; for the Cholesterol and Recurrent Events (CARE) Trial Investigators. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 2008; 117: Cavusoglu E, Chopra V, Gupta A, et al. Relation between red blood cell distribution width (RDW) and all-cause mortality at two years in an unselected population referred for coronary angiography. Int J Cardiol 2010; 141: Rhodes CJ, Wharton J, Howard LS, Gibbs JS, Wilkins MR. Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension. Heart 2011; 97: He W, Jia J, Chen J, et al. Comparison of prognostic value of red cell distribution width and NT-proBNP for short-term clinical outcomes in acute heart failure patients. Int Heart J 2014; 55: Nishitani-Yokoyama M, Miyauchi K, Shimada K, et al. Effects of phase II comprehensive cardiac rehabilitation on coronary plaque volume after acute coronary syndrome. Int Heart J 2015; 56: Van Craenenbroeck EM, Pelle AJ, Beckers PJ, et al. Red cell distribution width as a marker of impaired exercise tolerance in patients with chronic heart failure. Eur J Heart Fail 2012; 14: Campeau L. Letter: Grading of angina pectoris. Circulation 1976; 54: Oh J, Kang SM, Hong N, et al. Relation between red cell distribution width with echocardiographic parameters in patients with acute heart failure. J Card Fail 2009; 15: Fukuta H, Ohte N, Mukai S, et al. Elevated plasma levels of B- type natriuretic peptide but not C-reactive protein are associated with higher red cell distribution width in patients with coronary artery disease. Int Heart J 2009; 50: Balady GJ, Arena R, Sietsema K, et al; American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Peripheral Vascular Disease; Interdisciplinary Council on Quality of Care and Outcomes Research. Clinician s guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation 2010; 122: (Review) 12. Cohen RS, Karlin P, Yushak M, Mancini D, Maurer MS. The effect of erythropoietin on exercise capacity, left ventricular remodeling, pressure-volume relationships, and quality of life in older patients with anemia and heart failure with preserved ejection fraction. Congest Heart Fail 2010; 16: Wilkerson DP, Rittweger J, Berger NJ, Naish PF, Jones AM. Influence of recombinant human erythropoietin treatment on pulmonary O2 uptake kinetics during exercise in humans. J Physiol 2005; 568: Plenge U, Belhage B, Guadalupe-Grau A, et al. Erythropoietin treatment enhances muscle mitochondrial capacity in humans. Front Physiol 2012; 3: Goda A, Itoh H, Ebi Y, Kondo K, Maeda T, Shimada T. Erythropoietin treatment improves Peak VO 2 and oxygen uptake efficiency slope without changing VE vs. VCO 2 slope in anemic patients. Int J Clin Cardiol 2015; 2: Hambrecht R, Adams V, Erbs S, et al. Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation 2003; 107: Kojda G, Hambrecht R. Molecular mechanisms of vascular adaptations to exercise. Physical activity as an effective antioxidant therapy? Cardiovasc Res 2005; 67: (Review) 18. Zhao J, Tian Y, Cao J, Jin L, Ji L. Mechanism of endurance training-induced erythrocyte deformability in rats involves erythropoiesis. Clin Hemorheol Microcirc 2013; 53: Schmidt W, Maassen N, Trost F, Böning D. Training induced effects on blood volume, erythrocyte turnover and haemoglobin oxygen binding properties. Eur J Appl Physiol Occup Physiol 1988; 57: Green HJ, Jones LL, Hughson RL, Painter DC, Farrance BW. Training-induced hypervolemia: lack of an effect on oxygen utilization during exercise. Med Sci Sports Exerc 1987; 19:
RED CELL DISTRIBUTION WIDTH
RED CELL DISTRIBUTION WIDTH A NEW MARKER OF EXERCISE INTOLERANCE IN PATIENTS WITH CHRONIC HEART FAILURE Emeline Van Craenenbroeck, Paul Beckers, Nadine Possemiers, Christiaan Vrints, Viviane Conraads Cardiology
More informationChronic heart failure (CHF) is a major cause of morbidity
Systolic Blood Pressure Response to Exercise as a Predictor of Mortality in Patients With Chronic Heart Failure Yasuhiro Nishiyama, 1 MD, Hirohiko Morita, 1 MD, Haruhito Harada, 1 MD, Atsushi Katoh, 1
More informationBeta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes
Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes Seung-Jae Joo and other KAMIR-NIH investigators Department of Cardiology, Jeju National
More informationCardiac Drugs: Chapter 9 Worksheet Cardiac Agents. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate.
Complete the following. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate. 2. drugs affect the force of contraction and can be either positive or negative. 3.
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Table S1: Number and percentage of patients by age category Distribution of age Age
More informationRelationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome
Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Helder Dores, Luís Bronze Carvalho, Ingrid Rosário, Sílvio Leal, Maria João
More informationThe Who, How and When of Advanced Heart Failure Therapies. Disclosures. What is Advanced Heart Failure?
The Who, How and When of Advanced Heart Failure Therapies 9 th Annual Dartmouth Conference on Advances in Heart Failure Therapies Dartmouth-Hitchcock Medical Center Lebanon, NH May 20, 2013 Joseph G. Rogers,
More informationCHRONIC HEART FAILURE : WHAT ELSE COULD WE OFFER TO OUR PATIENTS? Cardiac Rehabilitation Society of Thailand
CHRONIC HEART FAILURE : WHAT ELSE COULD WE OFFER TO OUR PATIENTS? Cardiac Rehabilitation Society of Thailand ENHANCED EXTERNAL COUNTER PULSATION Piyanuj Ruckpanich, MD. Cardiac Rehabilitation Center Perfect
More informationValue of cardiac rehabilitation Prof. Dr. L Vanhees
Session: At the interface of hypertension and coronary heart disease haemodynamics, heart and hypertension Value of cardiac rehabilitation Prof. Dr. L Vanhees ESC Stockholm August 2010 Introduction There
More informationPrognostic Value of Cardiopulmonary Exercise Testing in Patients with Atrial Fibrillation
Prognostic Value of Cardiopulmonary Exercise Testing in Patients with Atrial Fibrillation Hidekazu Tsuneoka 1)2), Akira Koike 2), Osamu Nagayama 2), Koji Sakurada 2), Hitoshi Sawada 2), Kazutaka Aonuma
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Solomon SD, Uno H, Lewis EF, et al. Erythropoietic response
More informationCopeptin in heart failure: Associations with clinical characteristics and prognosis
Copeptin in heart failure: Associations with clinical characteristics and prognosis D. Berliner, N. Deubner, W. Fenske, S. Brenner, G. Güder, B. Allolio, R. Jahns, G. Ertl, CE. Angermann, S. Störk for
More informationCardiovascular Disorders Lecture 3 Coronar Artery Diseases
Cardiovascular Disorders Lecture 3 Coronar Artery Diseases By Prof. El Sayed Abdel Fattah Eid Lecturer of Internal Medicine Delta University Coronary Heart Diseases It is the leading cause of death in
More informationSteven S. Saliterman, MD, FACP
Ashley Wagner, Sochi 2014 www.gotceleb.com Steven S. Saliterman, MD, FACP Adjunct Professor Department of Biomedical Engineering, University of Minnesota http://saliterman.umn.edu/ Aerobic (Oxidative Phosphorylation)
More informationValue of echocardiography in chronic dyspnea
Value of echocardiography in chronic dyspnea Jahrestagung Schweizerische Gesellschaft für /Schweizerische Gesellschaft für Pneumologie B. Kaufmann 16.06.2016 Chronic dyspnea Shortness of breath lasting
More informationEffect of intravenous atropine on treadmill stress test results in patients with poor exercise capacity or chronotropic incompetence ABSTRACT
Effect of intravenous atropine on treadmill stress test results in patients with poor exercise capacity or chronotropic incompetence Samad Ghaffari, MD, Bahram Sohrabi, MD. ABSTRACT Objective: Exercise
More informationQuality Payment Program: Cardiology Specialty Measure Set
Quality Payment Program: Cardiology Specialty Set Title Number CMS Reporting Method(s) Heart Failure (HF): Angiotensin- Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Clinical perspective It was recently discovered that small RNAs, called micrornas, circulate freely and stably in human plasma. This finding has sparked interest in the potential
More informationDECLARATION OF CONFLICT OF INTEREST
DECLARATION OF CONFLICT OF INTEREST F. Baborski 1, I. Scuric 1, D. Cerovec 1, M. Novoselec 1, V. Slivnjak 1, K. Fuckar 1, N. Lakusic 1, Z. Vajdic 2, R. Bernat 3, K. Kapov-Svilicic 3 (1) Special Hospital
More informationGALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS
GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS Table of Contents List of authors pag 2 Supplemental figure I pag 3 Supplemental figure II pag 4 Supplemental
More informationDiagnosis is it really Heart Failure?
ESC Congress Munich - 25-29 August 2012 Heart Failure with Preserved Ejection Fraction From Bench to Bedside Diagnosis is it really Heart Failure? Prof. Burkert Pieske Department of Cardiology Med.University
More informationSupplement materials:
Supplement materials: Table S1: ICD-9 codes used to define prevalent comorbid conditions and incident conditions Comorbid condition ICD-9 code Hypertension 401-405 Diabetes mellitus 250.x Myocardial infarction
More informationClinical Considerations of High Intensity Interval Training (HIIT)
Clinical Considerations of High Intensity Interval Training (HIIT) Jenna Taylor Exercise Physiologist & Dietitian The Wesley Hospital PhD Candidate The University of Queensland What is High Intensity Interval
More informationPerformance and Quality Measures 1. NQF Measure Number. Coronary Artery Disease Measure Set
Unless indicated, the PINNACLE Registry measures are endorsed by the American College of Cardiology Foundation and the American Heart Association and may be used for purposes of health care insurance payer
More informationDECLARATION OF CONFLICT OF INTEREST
DECLARATION OF CONFLICT OF INTEREST Is there a mortality risk associated with aspirin use in heart failure? Results from a large community based cohort Margaret Bermingham, Mary-Kate Shanahan, Saki Miwa,
More informationHigh Intensity Interval Exercise Training in Cardiac Rehabilitation
High Intensity Interval Exercise Training in Cardiac Rehabilitation Prof. Leonard S.W. Li Hon. Clinical Professor, Department of Medicine, The University of Hong Kong Director, Rehabilitation Virtus Medical
More informationDECLARATION OF CONFLICT OF INTEREST. Nothing to disclose
DECLARATION OF CONFLICT OF INTEREST Nothing to disclose Four-Year Clinical Outcomes of the OLIVUS (Impact of OLmesartan on progression of coronary atherosclerosis; evaluation by IntraVascular UltraSound
More informationQuality Payment Program: Cardiology Specialty Measure Set
Measure Title * Reportable via PINNACLE α Reportable via Diabetes Collaborative CQMC v1.0 Measure High Priority Measure Cross Cutting Measure Heart Failure (HF): Angiotensin- Converting Enzyme (ACE) Inhibitor
More informationLCZ696 A First-in-Class Angiotensin Receptor Neprilysin Inhibitor
The Angiotensin Receptor Neprilysin Inhibitor LCZ696 in Heart Failure with Preserved Ejection Fraction The Prospective comparison of ARNI with ARB on Management Of heart failure with preserved ejection
More informationHFPEF Echo with Strain vs. MRI T1 Mapping
HFPEF Echo with Strain vs. MRI T1 Mapping Erik Schelbert, MD MS Director, Cardiovascular Magnetic Resonance Assistant Professor of Medicine Heart & Vascular Institute University of Pittsburgh Disclosures
More informationIvana Nedeljkovic, M Ostojic, V Giga, V Stojanov, J Stepanovic, A Djordjevic Dikic, B Beleslin, M Nikolic, M Petrovic, D Popovic
Combined cardiopulmonary exercise stress echocardiography test: New test for assessment of diastolic dysfunction in patients with hypertension Ivana Nedeljkovic, M Ostojic, V Giga, V Stojanov, J Stepanovic,
More informationThe ACC Heart Failure Guidelines
The ACC Heart Failure Guidelines Fakhr Alayoubi, Msc,R Ph President of SCCP Cardiology Clinical Pharmacist Assistant Professor At King Saud University King Khalid University Hospital Riyadh-KSA 2017 ACC/AHA/HFSA
More informationHeart Failure Clinician Guide JANUARY 2016
Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Heart Failure Clinician Guide JANUARY 2016 Introduction This evidence-based guideline summary is based on the 2016 National Heart Failure Guideline.
More informationRole of Clopidogrel in Acute Coronary Syndromes. Hossam Kandil,, MD. Professor of Cardiology Cairo University
Role of Clopidogrel in Acute Coronary Syndromes Hossam Kandil,, MD Professor of Cardiology Cairo University ACS Treatment Strategies Reperfusion/Revascularization Therapy Thrombolysis PCI (with/ without
More informationAntialdosterone treatment in heart failure
Update on the Treatment of Chronic Heart Failure 2012 Antialdosterone treatment in heart failure 전남의대윤현주 Chronic Heart Failure Prognosis of Heart failure Cecil, Text book of Internal Medicine, 22 th edition
More informationEvidence-Based Management of CAD: Last Decade Trials and Updated Guidelines
Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines Enrico Ferrari, MD Cardiac Surgery Unit Cardiocentro Ticino Foundation Lugano, Switzerland Conflict of Interests No conflict
More informationSupplementary Online Content
Supplementary Online Content Inohara T, Manandhar P, Kosinski A, et al. Association of renin-angiotensin inhibitor treatment with mortality and heart failure readmission in patients with transcatheter
More informationARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER:
ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM General Instructions: The Heart Failure Hospital Record Abstraction Form is completed for all heart failure-eligible cohort hospitalizations. Refer to
More informationAbstract Background: Methods: Results: Conclusions:
Two-Year Clinical and Angiographic Outcomes of Overlapping Sirolimusversus Paclitaxel- Eluting Stents in the Treatment of Diffuse Long Coronary Lesions Kang-Yin Chen 1,2, Seung-Woon Rha 1, Yong-Jian Li
More information2 Furthermore, quantitative coronary angiography
ORIGINAL PAPER Estimated Glomerular Filtration Rate Reversal by Blood Pressure Lowering in Chronic Kidney Disease: Japan Multicenter Investigation for Cardiovascular DiseaseB CKD Study Yoshiki Yui, MD;
More informationIndividual Study Table Referring to Part of Dossier: Volume: Page:
Synopsis Abbott Laboratories Name of Study Drug: Paricalcitol Capsules (ABT-358) (Zemplar ) Name of Active Ingredient: Paricalcitol Individual Study Table Referring to Part of Dossier: Volume: Page: (For
More informationRevascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing
Revascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing Evidence and Uncertainties Robert O. Bonow, MD, MS, MACC Northwestern University Feinberg School of Medicine
More informationHeart Failure in Women: Dr Goh Ping Ping Cardiologist Asian Heart & Vascular Centre
Heart Failure in Women: More than EF? Dr Goh Ping Ping Cardiologist Asian Heart & Vascular Centre Overview Review pathophysiology as it relates to diagnosis and management Rational approach to workup:
More informationLong-term prognostic value of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) changes within one year in patients with coronary heart disease
Long-term prognostic value of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) changes within one year in patients with coronary heart disease D. Dallmeier 1, D. Rothenbacher 2, W. Koenig 1, H. Brenner
More informationUpdates in Congestive Heart Failure
Updates in Congestive Heart Failure GREGORY YOST, DO JOHNSTOWN CARDIOVASCULAR ASSOCIATES 1/28/2018 Disclosures Edwards speaker on Sapien3 valves (TAVR) Stages A-D and NYHA Classes I-IV Stage A: High risk
More informationLow fractional diastolic pressure in the ascending aorta increased the risk of coronary heart disease
(2002) 16, 837 841 & 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh ORIGINAL ARTICLE Low fractional diastolic pressure in the ascending aorta increased the risk
More informationHeFSSA Practitioners Program 2017 Theme The Patient Journey: Feel Good and Live Long. Case Study 2
HeFSSA Practitioners Program 2017 Theme The Patient Journey: Feel Good and Live Long Case Study 2 HEART FAILURE WITH MID-RANGE EJECTION FRACTION TREATMENT OPTIONS CLINICAL CASE MEDICAL HISTORY 59-year-old
More informationEffect of Short-term Maximal Exercise on BNP Plasma Levels in. Healthy Individuals
1 Effect of Short-term Maximal Exercise on BNP Plasma Levels in Healthy Individuals Jan Krupicka, MD, Tomas Janota, MD, Zdislava Kasalova, MD, Jaromir Hradec, MD 3rd Department of Internal Medicine, 1st
More informationNew PINNACLE Measures The below measures for PINNACLE will be added as new measures to the outcomes reporting starting with Version 2.0.
New PINNACLE Measures The below measures for PINNACLE will be added as new measures to the outcomes reporting starting with Version 2.0. Measure Steward Measure Name Measure Description Rationale for Adding
More informationTrial to Reduce. Aranesp* Therapy. Cardiovascular Events with
Trial to Reduce Cardiovascular Events with Aranesp* Therapy John J.V. McMurray, Hajime Uno, Petr Jarolim, Akshay S. Desai, Dick de Zeeuw, Kai-Uwe Eckardt, Peter Ivanovich, Andrew S. Levey, Eldrin F. Lewis,
More informationAerobic Training Decreases B-Type Natriuretic Peptide Expression and Adrenergic Activation in Patients With Heart Failure
Journal of the American College of Cardiology Vol. 47, No. 9, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.12.050
More informationTopic Page: congestive heart failure
Topic Page: congestive heart failure Definition: congestive heart f ailure from Merriam-Webster's Collegiate(R) Dictionary (1930) : heart failure in which the heart is unable to maintain an adequate circulation
More informationConsensus Core Set: Cardiovascular Measures Version 1.0
Consensus Core Set: Cardiovascular s NQF 0330 Hospital 30-day, all-cause, riskstandardized readmission rate (RSRR) following heart failure hospitalization 0229 Hospital 30-day, all-cause, riskstandardized
More informationPathophysiology Department
UNIVERSITY OF MEDICINE - PLOVDIV Pathophysiology Department 15A Vasil Aprilov Blvd. Tel. +359 32 602311 Algorithm for interpretation of submaximal exercise tests in children S. Kostianev 1, B. Marinov
More informationUPDATES IN MANAGEMENT OF HF
UPDATES IN MANAGEMENT OF HF Jennifer R Brown MD, MS Heart Failure Specialist Medstar Cardiology Associates DC ACP Meeting Fall 2017 Disclosures: speaker bureau for novartis speaker bureau for actelion
More informationTicagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATO trial
compared with clopidogrel in patients with acute coronary syndromes the PLATO trial August 30, 2009 at 08.00 CET PLATO background In NSTE-ACS and STEMI, current guidelines recommend 12 months aspirin and
More informationCLINICIAN INTERVIEW RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE. An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA
RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA Dr Lincoff is an interventional cardiologist and the Vice Chairman for Research
More informationStress ECG is still Viable in Suleiman M Kharabsheh, MD, FACC Consultant Invasive Cardiologist KFHI KFSHRC-Riyadh
Stress ECG is still Viable in 2016 Suleiman M Kharabsheh, MD, FACC Consultant Invasive Cardiologist KFHI KFSHRC-Riyadh Stress ECG Do we still need stress ECG with all the advances we have in the CV field?
More informationThe Author(s) This article is published with open access by ASEAN Federation of Cardiology
DOI 10.7603/s40602-014-0011-3 ASEAN Heart Journal http://www.aseanheartjournal.org/ Vol. 22, no. 1, 60 65 (2014) ISSN: 2315-4551 Erratum Erratum to: Impact Of Sex On Clinical Characteristics And In-Hospital
More informationProgram Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name
Program Metrics The list below includes the metrics that will be calculated by the PINNACLE Registry for the outpatient office setting. These include metrics for, Atrial Fibrillation, Hypertension and.
More informationIron deficiency in heart failure
Iron deficiency in heart failure Piotr Ponikowski, MD, PhD, FESC Department of Heart Diseases, Wroclaw Medical University Centre for Heart Diseases, Military Hospital, Wroclaw, Poland Objectives Importance
More informationSubject: Assessment of Functional Capacity Melanie Elliott-Eller RN MSN Lee Lipsenthal MD February 2011
Subject: Assessment of Functional Capacity Melanie Elliott-Eller RN MSN Lee Lipsenthal MD February 2011 The Dr. Dean Ornish Program for Reversing Heart Disease has historically required a maximal exercise
More informationEvaluation of a diagnostic pathway in heart failure in primary care, using electrocardiography and brain natriuretic peptide guided echocardiography
Evaluation of a diagnostic pathway in heart failure in primary care, using electrocardiography and brain natriuretic peptide guided echocardiography Rebecka Karlsson Pardeep Jhund 1 Material and methods
More informationAPPENDIX F: CASE REPORT FORM
APPENDIX F: CASE REPORT FORM Instruction: Complete this form to notify all ACS admissions at your centre to National Cardiovascular Disease Registry. Where check boxes are provided, check ( ) one or more
More informationCongestive Heart Failure: Outpatient Management
The Chattanooga Heart Institute Cardiovascular Symposium Congestive Heart Failure: Outpatient Management E. Philip Lehman MD, MPP Disclosure No financial disclosures. Objectives Evidence-based therapy
More informationRandomized comparison of single versus double mammary coronary artery bypass grafting: 5 year outcomes of the Arterial Revascularization Trial
Randomized comparison of single versus double mammary coronary artery bypass grafting: 5 year outcomes of the Arterial Revascularization Trial Embargoed until 10:45 a.m. CT, Monday, Nov. 14, 2016 David
More informationCoronary Heart Disease. Relation Between Red Blood Cell Distribution Width and Cardiovascular Event Rate in People With Coronary Disease
Coronary Heart Disease Relation Between Red Blood Cell Distribution Width and Cardiovascular Event Rate in People With Coronary Disease Marcello Tonelli, MD, SM; Frank Sacks, MD; Malcolm Arnold, MD; Lemuel
More informationDUKECATHR Dataset Dictionary
DUKECATHR Dataset Dictionary Version of DUKECATH dataset for educational use that has been modified to be unsuitable for clinical research or publication (Created Date and Time: 28OCT16 14:35) Table of
More informationCardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition
Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac
More informationInnovation therapy in Heart Failure
Innovation therapy in Heart Failure P. Laothavorn September 2015 Topics of discussion Basic Knowledge about heart failure Standard therapy New emerging therapy References: standard Therapy in Heart Failure
More informationPatient characteristics Intervention Comparison Length of followup
ISCHAEMIA TESTING CHAPTER TESTING FOR MYCOCARDIAL ISCHAEMIA VERSUS NOT TESTING FOR MYOCARDIAL ISCHAEMIA Ref ID: 4154 Reference Wienbergen H, Kai GA, Schiele R et al. Actual clinical practice exercise ing
More informationEffects of Statins on Endothelial Function in Patients with Coronary Artery Disease
Effects of Statins on Endothelial Function in Patients with Coronary Artery Disease Iana I. Simova, MD; Stefan V. Denchev, PhD; Simeon I. Dimitrov, PhD Clinic of Cardiology, University Hospital Alexandrovska,
More informationHeart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United
Heart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United States, totaling about 750,000 individuals annually
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Wanner C, Inzucchi SE, Lachin JM, et al. Empagliflozin and
More informationDisclosure Information : No conflict of interest
Intravenous nicorandil improves symptoms and left ventricular diastolic function immediately in patients with acute heart failure : a randomized, controlled trial M. Shigekiyo, K. Harada, A. Okada, N.
More informationChapter 4: Cardiovascular Disease in Patients with CKD
Chapter 4: Cardiovascular Disease in Patients with CKD The prevalence of cardiovascular disease (CVD) was 65.8% among patients aged 66 and older who had chronic kidney disease (CKD), compared to 31.9%
More informationHeart failure is one of the most important
Mædica - a Journal of Clinical Medicine MAEDICA a Journal of Clinical Medicine 2013; 8(2): 124-128 ORIGINAL PAPERS Worsening of Heart Failure after Abdominal Surgery Can we predict it? Nora TOMA; Ruxandra
More informationDiabetic Patients: Current Evidence of Revascularization
Diabetic Patients: Current Evidence of Revascularization Alexandra J. Lansky, MD Yale University School of Medicine University College of London The Problem with Diabetic Patients Endothelial dysfunction
More informationMedical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI
Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist physician Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI Outcome objectives of the discussion: At the end of the
More informationSupplementary Online Content
Supplementary Online Content Nikolova AP, Hitzeman TC, Baum R, et al. Association of a novel diagnostic biomarker, the plasma cardiac bridging integrator 1 score, with heart failure with preserved ejection
More informationDobutamine-induced increase in heart rate is blunted by ivabradine treatment in patients with acutely decompensated heart failure
Dobutamine-induced increase in heart rate is blunted by ivabradine treatment in patients with acutely decompensated heart failure Yuksel Cavusoglu, KU Mert, A Nadir, F Mutlu, E Gencer, T Ulus, A Birdane
More informationThe evaluation of cardiovascular response to exercise in healthy Turkish children
The Turkish Journal of Pediatrics 2009; 51: 472-477 Original The evaluation of cardiovascular response to exercise in healthy Turkish children Hülya Akdur 1, Ahmet Bilge Sözen 2, Zerrin Yiğit 3, Funda
More informationLowering blood pressure (BP) in patients with type 2
Average Clinician-Measured Blood Pressures and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Ischemic Heart Disease in the EXAMINE Trial William B. White, MD; Fatima Jalil, MD;
More informationImpaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events
Diabetes Care Publish Ahead of Print, published online May 28, 2008 Chronotropic response in patients with diabetes Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts
More informationRight Ventricular Systolic Dysfunction is common in Hypertensive Heart Failure: A Prospective Study in Sub-Saharan Africa
Right Ventricular Systolic Dysfunction is common in Hypertensive Heart Failure: A Prospective Study in Sub-Saharan Africa 1 Ojji Dike B, Lecour Sandrine, Atherton John J, Blauwet Lori A, Alfa Jacob, Sliwa
More informationHeart Failure Clinician Guide JANUARY 2018
Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Heart Failure Clinician Guide JANUARY 2018 Introduction This evidence-based guideline summary is based on the 2018 National Heart Failure Guideline.
More informationCardiorenal Syndrome
SOCIEDAD ARGENTINA DE CARDIOLOGIA Cardiorenal Syndrome Joint session ESC-SAC ESC Congress 2012, Munich César A. Belziti Hospital Italiano de Buenos Aires I have no conflicts of interest to declare Cardiorenal
More informationImpact of Nicorandil on Renal Function in Patients With Acute Heart Failure and Pre-Existing Renal Dysfunction
Impact of Nicorandil on Renal Function in Patients With Acute Heart Failure and Pre-Existing Renal Dysfunction Masahito Shigekiyo, Kenji Harada, Ayumi Okada, Naho Terada, Hiroyoshi Yoshikawa, Akira Hirono,
More informationAcute Myocardial Infarction
Acute Myocardial Infarction Hafeza Shaikh, DO, FACC, RPVI Lourdes Cardiology Services Asst.Program Director, Cardiology Fellowship Associate Professor, ROWAN-SOM Acute Myocardial Infarction Definition:
More informationLEFT BUNDLE BRANCH BLOCK- BENIGN OR A HARBINGER OF HEART FAILURE? PROGNOSTIC INDICATOR?
LEFT BUNDLE BRANCH BLOCK- BENIGN OR A HARBINGER OF HEART FAILURE? PROGNOSTIC INDICATOR? Juan Cinca Department and Chair of Cardiology Hospital de la Santa Creu i Sant Pau Universitat Autònoma de Barcelona
More informationCardiac Rehabilitation for Heart Failure Patients. Jia Shen MD, MPH Assistant Professor of Medicine UC San Diego Health System
Cardiac Rehabilitation for Heart Failure Patients Jia Shen MD, MPH Assistant Professor of Medicine UC San Diego Health System Disclosures There are no conflict of interests related to this presentation.
More informationCandesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients
1/5 This site became the new ClinicalTrials.gov on June 19th. Learn more. We will be updating this site in phases. This allows us to move faster and to deliver better services. Show less IMPORTANT: Listing
More informationSummary Protocol ISRCTN / NCT REVIVED-BCIS2 Summary protocol version 4, May 2015 Page 1 of 6
Summary Protocol REVIVED-BCIS2 Summary protocol version 4, May 2015 Page 1 of 6 Background: Epidemiology In 2002, it was estimated that approximately 900,000 individuals in the United Kingdom had a diagnosis
More informationContinuing Medical Education Post-Test
Continuing Medical Education Post-Test Based on the information presented in this monograph, please choose one correct response for each of the following questions or statements. Record your answers on
More informationShort Communication Effect of Atorvastatin on E.C.G changes in Coronary artery disease Singh H 1, Gupta A 2, Bajaj VK 3, Gill BS 4, Singh J 5
Short Communication Effect of Atorvastatin on E.C.G changes in Coronary artery disease Singh H 1, Gupta A 2, Bajaj VK 3, Gill BS 4, Singh J 5 1 Dr. Harmanjit Singh Senior resident, Pharmacology PGIMER,
More informationLXIV: DRUGS: 4. RAS BLOCKADE
LXIV: DRUGS: 4. RAS BLOCKADE ACE Inhibitors Components of RAS Actions of Angiotensin i II Indications for ACEIs Contraindications RAS blockade in hypertension RAS blockade in CAD RAS blockade in HF Limitations
More informationHFpEF, Mito or Realidad?
HFpEF, Mito or Realidad? Ileana L. Piña, MD, MPH Professor of Medicine and Epidemiology/Population Health Associate Chief for Academic Affairs -- Cardiology Montefiore-Einstein Medical Center Bronx, NY
More informationDIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN
DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN Objectives Gain competence in evaluating chest pain Recognize features of moderate risk unstable angina Review initial management of UA and
More informationFrom left bundle branch block to cardiac failure
OF JOURNAL HYPERTENSION JH R RESEARCH Journal of HYPERTENSION RESEARCH www.hypertens.org/jhr Original Article J Hypertens Res (2017) 3(3):90 97 From left bundle branch block to cardiac failure Cătălina
More informationHeart Failure (HF) Treatment
Heart Failure (HF) Treatment Heart Failure (HF) Complex, progressive disorder. The heart is unable to pump sufficient blood to meet the needs of the body. Its cardinal symptoms are dyspnea, fatigue, and
More information